НовостиBenzingaOS Therapies Completes Requalification Of Phase 2b Herlystic Drug Substance For Confirmatory Phase 3 Trial OS Therapies Completes Requalification Of Phase 2b Herlystic Drug Substance For Confirmatory Phase 3 Trial Benzinga 2026.11.05 13:14 (GMT+0) Открыть на Benzinga Другие новости